Literature DB >> 8006524

Biliary cholesterol secretion and bile acid formation in the hamster: the role of newly synthesized cholesterol.

J Scheibner1, M Fuchs, E Hörmann, G Tauber, E F Stange.   

Abstract

In order to define the source of cholesterol for bile acid synthesis and biliary cholesterol, hamsters with an extracorporeal bile duct received an intraperitoneal bolus of [3H]water labeling newly synthesized cholesterol. Thereafter the enterohepatic circulation was interrupted and a nutrient solution was infused during the experimental period of 78 h. In a separate group, pravastatin was administered (54-78 h) to allow discrimination of 3H-labeled cholesterol recycling from plasma and newly synthesized hepatic cholesterol late during the experiment. In controls, newly synthesized biliary cholesterol and primary bile acids derived from cholesterol newly synthesized during the experiment amounted to 5% and 12% immediately after depletion of the bile acid pool (6-9 h), respectively. After longterm bile diversion these proportions increased to 56-63%, whereas 71% of plasma cholesterol was labeled. Pravastatin inhibited the secretion of biliary cholesterol, cholate, and chenodeoxycholate by 30, 50, and 44%, respectively. In contrast, the preinfusion tritium label was suppressed by a maximum of 16%, 14%, and 26%, respectively, reflecting the contribution of cholesterol newly synthesized in the hepatocyte as opposed to labeled cholesterol recycling from the plasma. It is concluded that in the hamster newly synthesized cholesterol is of minor importance as substrate for bile acid synthesis as well as biliary cholesterol, both under near physiologic conditions and after long-term bile diversion. Moreover, the hepatic cholesterol pools subserving the synthesis of the primary bile acids are identical but appear to be different from that of biliary cholesterol directly after the depletion of the enterohepatic bile acids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8006524

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Short-term effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor on cholesterol and bile acid synthesis in humans.

Authors:  T Yoshida; A Honda; J Shoda; M Abei; Y Matsuzaki; N Tanaka; H Miyazaki; T Osuga
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

2.  The contribution of newly synthesized cholesterol to biliary cholesterol in healthy humans.

Authors:  J Scheibner; K Lange; K Empen; E F Stange
Journal:  Z Ernahrungswiss       Date:  1997-12

3.  Effect of prebiotic fibre supplementation on hepatic gene expression and serum lipids: a dose-response study in JCR:LA-cp rats.

Authors:  Jill A Parnell; Raylene A Reimer
Journal:  Br J Nutr       Date:  2009-12-21       Impact factor: 3.718

4.  Reverse cholesterol transport is elevated in carboxyl ester lipase-knockout mice.

Authors:  Lisa M Camarota; Laura A Woollett; Philip N Howles
Journal:  FASEB J       Date:  2011-01-06       Impact factor: 5.191

5.  Cholesterol synthesis inhibition distal to squalene upregulates biliary phospholipid secretion and counteracts cholelithiasis in the genetically prone C57L/J mouse.

Authors:  G A Clarke; G Bouchard; B Paigen; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

6.  Role of the ABCG8 19H risk allele in cholesterol absorption and gallstone disease.

Authors:  Olga Renner; Dieter Lütjohann; Dominique Richter; André Strohmeyer; Silke Schimmel; Oliver Müller; Eduard F Stange; Simone Harsch
Journal:  BMC Gastroenterol       Date:  2013-02-13       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.